Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)

Phase Distribution

Ph early_phase_1
1
14%
Ph phase_2
4
57%
Ph phase_3
1
14%
Ph phase_4
1
14%

Phase Distribution

1

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 2Efficacy & side effects
4(57.1%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(4)
Other(3)

Detailed Status

Completed4
unknown3

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (14.3%)
Phase 24 (57.1%)
Phase 31 (14.3%)
Phase 41 (14.3%)

Trials by Status

unknown343%
completed457%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_2

Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma

NCT00866749
unknownphase_2

Modified MRCUKALLⅫ/ECOGE2993 Regimen for ALL

NCT02660762
unknownphase_3

High-dose Intravenous Methotrexate Versus Intrathecal Methotrexate for Central Nervous System Prophylaxis in DLBCL

NCT03123718
unknownearly_phase_1

Intrathecal Methotrexate for Progressive Multiple Sclerosis: An Open Label Single Arm Study

NCT02644044
completedphase_2

Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal Metastasis

NCT01281696
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT00866749Phase 2

Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma

Completed
NCT02660762Phase 2

Modified MRCUKALLⅫ/ECOGE2993 Regimen for ALL

Unknown
NCT03123718Phase 3

High-dose Intravenous Methotrexate Versus Intrathecal Methotrexate for Central Nervous System Prophylaxis in DLBCL

Unknown
NCT02644044Early Phase 1

Intrathecal Methotrexate for Progressive Multiple Sclerosis: An Open Label Single Arm Study

Unknown
NCT01281696Phase 2

Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal Metastasis

Completed
NCT00210379Phase 2

Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's Lymphoma

Completed
NCT00029523Phase 4

DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7